Trial Profile
The Effect of Ondansetron on Cardiac Output in Elective Cesarean Deliveries Under Spinal Anesthesia: A Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Pharmacodynamics
- 01 Dec 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2013 New trial record